Skip To Main Content
Aditya Barve on Muck Rack

Aditya Barve

As seen in: Science Magazine, BioRxiv, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aditya

Contact Aditya, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes

|
By Emily Hendrix, Heather Lin Verified, Aditya Barve, Petter Bjornstad, Ye Ji Choi, Phoom Narongkiatikhun, Anil Karihaloo, Pottumarthi Prasad, Kalie L. Tommerdahl, Carissa Birznieks, Antoine Clarke, Yesmino T. Elia, Jacqueline Curtis, Matteo D’Antonio, Hailey E. Hampson, Long Yuan, Jenny E. Kanter, Karin E. Bornfeldt, Tomas Vaisar, Lu-Ping Li, Maninderpal Sethi, Shivani Ramesh, Cheril Clarson, Dylan Weissenkampen, Sarah A. van Eeghen
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Sodium-glucose cotransporter-2 (SGLT2) inhibitors can slow diabetic kidney disease, but less is known about their mechanistic benefits in type 1 diabetes. Bjornstad et al.
Open in Who Shared Issue with article?

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis

|
By Emily Hendrix, Heather Lin Verified, Aditya Barve, Tradite Neziraj, Elisabeth Pössnecker, Angela A. Wang, Paul Saary, Adrian-Minh Schumacher, Florian Ingelfinger, Amandine Mathias, Edoardo Galli, Michelle Zuo, Samuel Jones, Vasiliki Pantazou, Joep Killestein, Sabine Schädelin, Pascal Benkert, Cristina Granziera, Caroline Pot, Antje Bischof, Jan Hendrik Niess, Tobias Derfuss, Charlotte Teunissen, Marco Häfelfinger, Magdalena Filipowicz Sinnreich
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Anti-CD20 therapies deplete B cells and are an effective disease-modifying treatment avenue for multiple sclerosis (MS). However, which B cell subtypes are responsible for this therapeutic success remains unknown. Here, Neziraj et al.
Open in Who Shared Issue with article?

Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models

|
By Emily Hendrix, Heather Lin Verified, Aditya Barve, Mathieu Rouanne, Noah Chen, Dylan L. Mariuzza, Zaofeng Yang, Fangda Li, Thomas Savage, Rosa Vincent, Cathy L. Mendelsohn, Tal Danino, Nicholas Arpaia, Kenia de los Santos-Alexis
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Bladder cancer is often treated with Bacillus Calmette-Guérin immunotherapy, a bacterial therapy delivered intravesically; however, its effect on the host humoral immune response during immune checkpoint blockade (ICB) is not known, limiting its potential to improve therapy. Here, Rouanne et al.
Open in Who Shared Issue with article?
See all 12 articles